Denali Advisors’s Chemours CC Stock Holding History

Denali Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30	Closed	-$1K	–	388
2021 Q3	$1K	Sell	30 -47	-61%	-$1.52K	﹤0.01%	268
2021 Q2	$3K	Buy	+77	New	+$2.55K	﹤0.01%	241

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Denali Advisors's CC Position: Q4 2021 in Review

Denali Advisors sold out of Chemours (CC) in Q4 2021, closing a stake of 30 shares — an estimated $1K sold.

Denali Advisors first reported a position in CC in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 504 funds tracked by Wall St. Rank hold CC as of Q4 2021.

Denali Advisors reported no remaining Chemours position as of Q4 2021 after selling out during the quarter.
Denali Advisors sold 30 Chemours shares in Q4 2021, an estimated $1K.
Denali Advisors first reported a position in Chemours in Q2 2021 and held it in 2 quarters.
Denali Advisors's Chemours position peaked at $3K in Q2 2021.
504 funds tracked by Wall St. Rank held Chemours as of Q4 2021.

Based on Denali Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.